Table 4.
Association between MLR and 90-day mortality.
| Variables | Model 1 | Model 2 | Model 3 | |||
|---|---|---|---|---|---|---|
| HR (95% CI) | p value | HR (95% CI) | p value | HR (95% CI) | p value | |
| MLR, per 0.1 | 1.016 (1.011–1.022) | < 0.001 | 1.011 (1.004–1.018) | 0.001 | 1.009 (1.002–1.016) | 0.010 |
| MLR < 0.28 | Ref. | – | Ref. | – | Ref. | – |
| 0.28 ≤ MLR ≤ 0.71 | 1.472 (1.167–1.857) | 0.001 | 1.449 (1.147–1.830) | 0.002 | 1.397 (1.105–1.765) | 0.005 |
| MLR > 0.71 | 2.429 (1.905–3.098) | < 0.001 | 2.070 (1.619–2.647) | < 0.001 | 1.898 (1.478–2.437) | < 0.001 |
MLR, monocyte-to-lymphocyte ratio; Ref, reference; HR, hazard ratio; CI, confidence interval. Model 1: unadjusted. Model 2: adjust for: age; gender; weight; CAD; CHF; hypertension; and SOFA score. Model 3; adjust for: Model 2 plus CKD stage; HGB; platelet; potassium; sodium; phosphate; Bun; ALB; ALP; ALT; AST; glucose; PT; PTT and eGFR.